BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 11821508)

  • 21. Topical corticosteroids and bullous pemphigoid.
    Hull CM; McKenna JK; Zone JJ
    Arch Dermatol; 2003 Feb; 139(2):225-6. PubMed ID: 12588236
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of bullous pemphigoid with topical clobetasol propionate.
    Westerhof W
    J Am Acad Dermatol; 1989 Mar; 20(3):458-61. PubMed ID: 2645323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interventions for bullous pemphigoid.
    Kirtschig G; Middleton P; Bennett C; Murrell DF; Wojnarowska F; Khumalo NP
    Cochrane Database Syst Rev; 2010 Oct; 2010(10):CD002292. PubMed ID: 20927731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of bullous pemphigoid.
    Fontaine J; Joly P; Roujeau JC
    J Dermatol; 2003 Feb; 30(2):83-90. PubMed ID: 12692373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
    N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetracycline, nicotinamide, and lesionally administered clobetasol as a therapeutic option to prednisone in patients with bullous pemphigoid: a comparative, retrospective analysis of 106 patients with long-term follow-up.
    Kalinska-Bienias A; Kowalczyk E; Jagielski P; Kowalewski C; Wozniak K
    Int J Dermatol; 2019 Feb; 58(2):172-177. PubMed ID: 30350359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose methylprednisolone in the treatment of bullous pemphigoid.
    Siegel J; Eaglstein WH
    Arch Dermatol; 1984 Sep; 120(9):1157-65. PubMed ID: 6383221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma.
    Schuh S; Reisman J; Alshehri M; Dupuis A; Corey M; Arseneault R; Alothman G; Tennis O; Canny G
    N Engl J Med; 2000 Sep; 343(10):689-94. PubMed ID: 10974132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Anderson MM; Keltner JL; Shults WT; Kaufman DI; Buckley EG; Corbett JJ; Kupersmith MJ; Miller NR
    N Engl J Med; 1992 Feb; 326(9):581-8. PubMed ID: 1734247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [One year follow-up of patients with bullous pemphigoid].
    Doffoel-Hantz V; Sparsa A; Marin B; Durox H; Bonnetblanc JM; Bédane C
    Ann Dermatol Venereol; 2009 May; 136(5):407-11. PubMed ID: 19442795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.
    Bernard P; Reguiai Z; Tancrède-Bohin E; Cordel N; Plantin P; Pauwels C; Vaillant L; Grange F; Richard-Lallemand MA; Sassolas B; Roujeau JC; Lok C; Picard-Dahan C; Chosidow O; Vitry F; Joly P
    Arch Dermatol; 2009 May; 145(5):537-42. PubMed ID: 19451497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial.
    Campisi G; Giandalia G; De Caro V; Di Liberto C; Aricò P; Giannola LI
    Br J Dermatol; 2004 May; 150(5):984-90. PubMed ID: 15149513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study.
    Faghihi G; Iraji F; Shahingohar A; Saidat A
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):531-6. PubMed ID: 18284511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A startling beginning! Revolutionary local therapy of bullous pemphigoid?].
    Breit R
    Hautarzt; 2002 Jun; 53(6):439-40. PubMed ID: 12132304
    [No Abstract]   [Full Text] [Related]  

  • 35. [Kaposi's disease: an unusual side-effect of topical corticosteroids].
    Boudhir H; Mael-Ainin M; Senouci K; Hassam B; Benzekri L
    Ann Dermatol Venereol; 2013; 140(6-7):459-61. PubMed ID: 23773746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid.
    Guillaume JC; Vaillant L; Bernard P; Picard C; Prost C; Labeille B; Guillot B; Foldès-Pauwels C; Prigent F; Joly P
    Arch Dermatol; 1993 Jan; 129(1):49-53. PubMed ID: 8420491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral and topical corticosteroids in bullous pemphigoid.
    Korman NJ
    N Engl J Med; 2002 Jul; 347(2):143-5; author reply 143-5. PubMed ID: 12117000
    [No Abstract]   [Full Text] [Related]  

  • 38. Tinea incognito in an old patient with bullous pemphigoid receiving topical high potency steroids.
    Liu ZH; Shen H
    J Mycol Med; 2015 Sep; 25(3):245-6. PubMed ID: 26278826
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases.
    Schmidt E; Kraensel R; Goebeler M; Sinkgraven R; Bröcker EB; Rzany B; Zillikens D
    Cutis; 2005 Sep; 76(3):205-9. PubMed ID: 16268266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of skin concentrations following topical versus oral corticosteroid treatment: reconsidering the treatment of common inflammatory dermatoses.
    McClain RW; Yentzer BA; Feldman SR
    J Drugs Dermatol; 2009 Dec; 8(12):1076-9. PubMed ID: 20027934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.